Anteris Technologies Global vs Volitionrx
Anteris Technologies Global and Volitionrx are similar in size: $1.9m and $1.7m of revenue in their latest fiscal years. Volitionrx grew faster (40.0% against -29.2%). Volitionrx kept more of each dollar of sales as profit: a net margin of -1352.2% against -4921.3%.
| Latest fiscal year | Anteris Technologies GlobalAVR, 2025 | VolitionrxVNRX, 2025 |
|---|---|---|
| Revenue | $1.9m | $1.7m |
| Revenue growth | -29.2% | 40.0% |
| Net income | −$94.1m | −$23.4m |
| Operating margin | -4908.2% | -1258.5% |
| Net margin | -4921.3% | -1352.2% |
| Return on equity | — | — |
| Free cash flow | −$79.8m | −$19.8m |
| Cash | $6.7m | $1.1m |
| Total debt | $38,000 | $8.2m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 174 | — |
| Market value | $555m | $2.3m |
| Price vs our value range | — | — |
| Moat score | — | 12 (Weak) |
| Insider trades, 12 months | 8 buys, 13 sales | 1 buys, 0 sales |